PARADIGMS: Fingolimod Effective, Well Tolerated in Children PARADIGMS: Fingolimod Effective, Well Tolerated in Children
Results show an 82% reduced annualized relapse rate among pediatric patients with multiple sclerosis taking fingolimod compared with those taking interferon-beta1a.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Children | Gilenya | Health | Multiple Sclerosis | Neurology | Neurosurgery | Pediatrics | Rebif